Paul Rafferty

585 total citations
21 papers, 413 citations indexed

About

Paul Rafferty is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Paul Rafferty has authored 21 papers receiving a total of 413 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Organic Chemistry, 7 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Paul Rafferty's work include Synthesis and Reactivity of Heterocycles (5 papers), Synthesis and Biological Evaluation (5 papers) and Synthesis and Characterization of Heterocyclic Compounds (3 papers). Paul Rafferty is often cited by papers focused on Synthesis and Reactivity of Heterocycles (5 papers), Synthesis and Biological Evaluation (5 papers) and Synthesis and Characterization of Heterocyclic Compounds (3 papers). Paul Rafferty collaborates with scholars based in United Kingdom, United States and China. Paul Rafferty's co-authors include David J. Calderwood, T. L. Gilchrist, R. C. STORR, Oliver B. Sutcliffe, Gavin C. Hirst, Gurnos Jones, Andrew Burchat, Lee D. Arnold, Joanne Kamens and R. W. Dixon and has published in prestigious journals such as Chemical Communications, Brain Research and The Journal of Organic Chemistry.

In The Last Decade

Paul Rafferty

21 papers receiving 398 citations

Peers

Paul Rafferty
Andrew Burchat United States
Robert H. Gruninger United States
Richard L. Wife Netherlands
Deborah S. Mortensen United States
Shendong Yuan United States
Scott A. Watkins United States
Peter R. Seoane United States
Janak Padia United States
Andrew Burchat United States
Paul Rafferty
Citations per year, relative to Paul Rafferty Paul Rafferty (= 1×) peers Andrew Burchat

Countries citing papers authored by Paul Rafferty

Since Specialization
Citations

This map shows the geographic impact of Paul Rafferty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Rafferty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Rafferty more than expected).

Fields of papers citing papers by Paul Rafferty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Rafferty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Rafferty. The network helps show where Paul Rafferty may publish in the future.

Co-authorship network of co-authors of Paul Rafferty

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Rafferty. A scholar is included among the top collaborators of Paul Rafferty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Rafferty. Paul Rafferty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Woller, Kevin R., Anna Ericsson, Haipeng Chen, et al.. (2008). Synthesis and in vitro activity of N′-cyano-4-(2-phenylacetyl)-N-o-tolylpiperazine-1-carboximidamide P2X7 antagonists. Bioorganic & Medicinal Chemistry Letters. 18(6). 2093–2096. 13 indexed citations
2.
Donnelly‐Roberts, Diana L., Michael Friedman, Jonathan S. George, et al.. (2008). Synthesis and activity of N-cyanoguanidine-piperazine P2X7 antagonists. Bioorganic & Medicinal Chemistry Letters. 18(14). 3848–3851. 9 indexed citations
3.
Dinges, Jürgen, Irini Akritopoulou‐Zanze, Lee D. Arnold, et al.. (2006). Hit-to-lead optimization of 1,4-dihydroindeno[1,2-c]pyrazoles as a novel class of KDR kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(16). 4371–4375. 19 indexed citations
4.
Heyman, H. Robin, Robin R. Frey, Peter F. Bousquet, et al.. (2006). Thienopyridine urea inhibitors of KDR kinase. Bioorganic & Medicinal Chemistry Letters. 17(5). 1246–1249. 33 indexed citations
5.
Dinges, Jürgen, Peter F. Bousquet, George A. Cunha, et al.. (2006). 1,4-Dihydroindeno[1,2-c]pyrazoles as novel multitargeted receptor tyrosine kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(16). 4266–4271. 15 indexed citations
6.
Calderwood, David J., et al.. (2002). Pyrrolo[2,3-d]pyrimidines containing diverse N-7 substituents as potent inhibitors of Lck. Bioorganic & Medicinal Chemistry Letters. 12(12). 1683–1686. 41 indexed citations
7.
Calderwood, David J., et al.. (2002). Pyrrolo[2,3‐d]pyrimidines Containing Diverse N‐7 Substituents as Potent Inhibitors of Lck.. ChemInform. 33(40). 242–242. 1 indexed citations
8.
Burchat, Andrew, David J. Calderwood, Michael Friedman, et al.. (2002). Pyrazolo[3,4-d]pyrimidines containing an extended 3-substituent as potent inhibitors of Lck — a selectivity insight. Bioorganic & Medicinal Chemistry Letters. 12(12). 1687–1690. 48 indexed citations
9.
Burchat, Andrew, David J. Calderwood, Michael Friedman, et al.. (2002). Pyrazolo[3,4‐d]pyrimidines Containing an Extended 3‐Substituent as Potent Inhibitors of Lck — A Selectivity Insight.. ChemInform. 33(39). 158–158. 1 indexed citations
10.
Burchat, Andrew, et al.. (2000). Pyrrolo[2,3-d]pyrimidines Containing an Extended 5-Substituent as Potent and Selective Inhibitors of lck II. Bioorganic & Medicinal Chemistry Letters. 10(19). 2171–2174. 40 indexed citations
11.
Arnold, Lee D., David J. Calderwood, R. W. Dixon, et al.. (2000). Pyrrolo[2,3-d]pyrimidines containing an extended 5-substituent as potent and selective inhibitors of lck I. Bioorganic & Medicinal Chemistry Letters. 10(19). 2167–2170. 68 indexed citations
12.
Sutcliffe, Oliver B., R. C. STORR, T. L. Gilchrist, Paul Rafferty, & Andrew P. Crew. (2000). Azafulvenium methides: new extended dipolar systems. Chemical Communications. 675–676. 17 indexed citations
13.
Sutcliffe, Oliver B., R. C. STORR, T. L. Gilchrist, & Paul Rafferty. (2000). Cycloadditions to Pyrrolo[1,2-c]thiazoles and Pyrazolo[1,5-c]thiazoles. Tetrahedron. 56(51). 10011–10021. 19 indexed citations
14.
Calderwood, David J., et al.. (1997). Organocerium reactions of benzamides and thiobenzamides: A direct synthesis of tertiary carbinamines. Tetrahedron Letters. 38(7). 1241–1244. 19 indexed citations
15.
Boden, P., Barrie W. Bycroft, Siri Ram Chhabra, et al.. (1986). The action of natural and synthetic isomers of quisqualic acid at a well-defined glutamatergic synapse. Brain Research. 385(2). 205–211. 19 indexed citations
16.
Rafferty, Paul, et al.. (1982). Pyrido[1,2-a]azepines. A correction. The Journal of Organic Chemistry. 47(14). 2792–2792. 3 indexed citations
17.
Rafferty, Paul, et al.. (1979). Crystal structure of 2,6-di-tert-butyl-5,6-epoxy-2,4-dihydroxy-4-methyl-1,3-cyclohexanedione, an oxidation product of 2,6-di-tert-butyl-4-methylphenol (BHT). Acta Crystallographica Section B. 35(9). 2067–2071. 1 indexed citations
18.
Jones, Gurnos & Paul Rafferty. (1979). The synthesis of annulated pyridazines by cycloaddition of azodicarboxylates to vinyl heterocycles. Tetrahedron. 35(17). 2027–2033. 16 indexed citations
19.
Jones, Gurnos, et al.. (1978). Syntheses using isoxazoles—V. Tetrahedron. 34(10). 1581–1583. 2 indexed citations
20.
Jones, Gurnos & Paul Rafferty. (1978). A synthesis of annulated pyridazines by cycloaddition of azodicarboxylates to vinylpyridines. Tetrahedron Letters. 19(30). 2731–2734. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026